Waldenburg/Germany, Lanskroun/Czech Republic, 29 June 2017 – Würth Elektronik eiSos is pleased to announce its cooperation with and support for the European Passive Components Institute s.r.o. (EPCI). The cooperation includes the development of easy-to-use web-based tools for designers of passive component hardware, educational tools for schools, and promotion of the passive components industry to everyone interested in this field.
Würth Elektronik eiSos has become a gold sponsor of EPCI and co-sponsor of the upcoming international Passive Components Networking Days PCNS in Brno, Czech Republic, in September 2017.
“Our aim is to be a valued part of the upcoming new digital age based on advanced modern electronics. Designers of such enabling technologies prefer open web sources to get the latest information, benchmarking, knowledge base, etc. Easy to find, online resources of passive components information, such as EPCI activities and its website, represent one of the important communication channels that are growing in influence,” said Alexander Gerfer, CTO Würth Elektronik eiSos Group.
“It is our great honour to establish a cooperation with leading European passive component manufacturer Würth Elektronik eiSos who shares our visions and missions. It is a further strong motivation for us to continue in our efforts to support the passive components industry and develop new web-based online tools,” said Tomas Zednicek, President of EPCI.
Top image: Tomas Zednicek, President of EPCI
Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…
The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…
More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…
The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…
Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…
This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…